Possible treatment for retinitis pigmentosa
Date of release: 2025-06-13T02:52:56
Article short description:
Researches of Korea Advanced Institute of Science and Technologyy (KAIST) developed antibody that binds to PROX1 protein and conducted tests on mouses which had shown that blocking this protein allows to eye regenerate and restore a vision. The test had shown that vision was brought back after 6 months since injection antibodies. Human trials are planned for 2028.
Full article:
Researches of Korea Advanced Institute of Science and Technologyy (KAIST) developed antibody that binds to PROX1 protein and conducted tests on mouses which had shown that blocking this protein allows to eye regenerate and restore a vision. The test had shown that vision was brought back after 6 months since injection antibodies. Human trials are planned for 2028.
MEDIA SECTION:
Gallery:
video:
Sources:
newatlas.com impactlab.com wikipedia.org KAIST wikipedia.org Retinitis_pigmentosa